Plain-English translation of NCT03736382 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new approach to treating obstructive sleep apnea that combines two therapies: mild intermittent hypoxia (brief sessions where you breathe air with slightly less oxygen) plus your regular CPAP machine at night. Researchers believe this combination might help your body better regulate breathing and reduce the harmful effects of sleep apnea, including high blood pressure.
While CPAP machines are the standard treatment for sleep apnea, they don't always fully prevent the health problems caused by the condition—partly because people don't always use them consistently. This trial is testing whether adding the new treatment might work better to protect your heart, blood pressure, and overall health.
You likely qualify if…
You likely don't qualify if…
If you join, you'll visit the research center for 15 sessions over 3 weeks. During each daytime visit, you'll breathe through a mask that delivers the mild oxygen-reduction sessions for about 20–30 minutes. At night, you'll use your CPAP machine as usual. Researchers will measure your breathing, oxygen levels, blood pressure, and other markers of health before, during, and after the treatment period.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States